Samantha Xavier: Successfully Defended My PhD Thesis on P-Selectin as a Biomarker for Venous Thromboembolism
Samantha Xavier, PHD Fellow in The Arctic University of Norway, shared a post on LinkedIn:
“Yesterday, I had the privilege and honor of defending my thesis (P-selectin as a biomarker for venous thromboembolism) for the degree of philosophiae doctor.
After a long day with lots of wonderful discussion, I walked out of the room as Dr. Xavier and am so grateful to everyone who has supported me along the way.
A huge thank you to UiT- The Arctic University of Norway for giving me the opportunity to pursue my PhD, my supervisors and colleagues at the Thrombosis Research Center, and to the committee who reviewed and challenged my thesis for making me feel like a scientific peer for the first time in my academic journey.
I will look back fondly on this day for years to come.
Now that I have wrapped up my PhD journey, I’m on the hunt for opportunities in the Greater Oslo area where I can use my expertise with epidemiology and biostatistics focusing on population-based cohorts to generate real-world evidence. If you or someone you know is hiring, feel free to reach out!” 
Stay updated with Hemostasis Today.
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:38Jecko Thachil: Can We Predict and Prevent Bleeding in APL?
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026